Table 4.
BMI, NRS 2002, and laboratory results: differences before and after treatment in the HPV(-) and HPV(+) groups separately.
| Feature | All | HPV(-) | HPV(+) |
|---|---|---|---|
| Weight 0 (kg) | 75.65 ± 15.24 (44–111) | 72.38 ± 15.24 (44–104.80) | 79.41 ± 14.64 (46–111) |
| Weight 1(kg) | 71.88 ± 14.17 (42–110) | 70.56 ± 15.24 (42–94.70) | 72.96 ± 14.81 (45–110) |
| p | <0.0001 | <0.0001 | <0.0001 |
| p H–B | <0.0001 | <0.0001 | <0.0001 |
| BMI 0 (kg/m2) | 26.84 ± 4.65 (17.21–40.44) | 25.75 ± 4.70 (17.21–37.58) | 28.10 ± 4.30 (18.20–40.44) |
| BMI 1 (kg/m2) | 25.26 ± 4.16 (17.26–31.81) | 24.69 ± 4.04 (17.26–33.96) | 25.72 ± 4.24 (17.80–37.81) |
| p | <0.0001 | <0.0001 | <0.0001 |
| p H–B | <0.0001 | <0.0001 | <0.0001 |
| NRS 2002 0 | 0.35 ± 0.77 (0–4) | 0.41 ± 0.87 (0–4) | 0.28 ± 0.64 (0–4) |
| NRS 2002 1 | 3.20 ± 1.11 (1–5) | 2.98 ± 1.09 (1–5) | 3.39 ± 1.10 (1–5) |
| p | <0.0001 | <0.0001 | <0.0001 |
| p H–B | <0.0001 | <0.0001 | <0.0001 |
| CRP 0 (g/L) | 5.15 ± 7.07 (0.16–36.90) | 6.79 ± 8.39 (0.16–36.90) | 3.40 ± 4.80 (0.17–27.20) |
| CRP 1 (g/L) | 26.60 ± 35.93 (0.17–197.00) | 30.96 ± 44.43 (0.20–197.00) | 22.00 ± 23.50 (0.17–87.20) |
| p | <0.0001 | <0.0001 | <0.0001 |
| p H–B | <0.0001 | <0.0001 | <0.0001 |
| Albumin 0 (g/L) | 41.67 ± 3.68 (33.00–50.00) | 41.58 ± 3.65 (33.00–49.00) | 41.77 ± 3.74 (32.00–50.00) |
| Albumin 1 (g/L) | 36.95 ± 3.92 (30.00–49.00) | 37.05 ± 4.11 (30.00–47.00) | 36.84 ± 3.75 (30.00–49.00) |
| p | <0.0001 | <0.0001 | <0.0001 |
| p H–B | <0.0001 | <0.0001 | <0.0001 |
| Prealbumin 0 (g/L) | 0.28 ± 0.08 (0.13–0.52) | 0.26 ± 0.09 (0.13–0.52) | 0.29 ± 0.07 (0.18–0.45) |
| Prealbumin 1 (g/L) | 0.20 ± 0.08 (0.08–0.49) | 0.19 ± 0.07 (0.08–0.35) | 0.21 ± 0.09 (0.09–0.49) |
| p | <0.0001 | 0.005 | 0.0004 |
| p H–B | <0.0001 | 0.005 | 0.0008 |
| Hemoglobin 0 (g/dL) | 13.97 ± 1.50 (10.60–17.40) | 10.60 ± 1.51 (12.85–15.35) | 13.88 ± 1.51 (10.80–16.90) |
| Hemoglobin 1 (g/dL) | 12.70 ± 1.50 (9.40–16.30) | 12.29 ± 1.46 (9.40–16.30) | 12.03 ± 1.54 (9.50–15.80) |
| p | <0.0001 | <0.0001 | <0.0001 |
| p H–B | <0.0001 | <0.0001 | <0.0001 |
| TLC 0 (/mm3) | 1.90 ± 0.72 (0.57–4.84) | 1.91 ± 0.71 (0.65–3.94) | 1.89 ± 0.73 (0.57–4.54) |
| TLC 1 (/mm3) | 0.62 ± 0.37 (0.11–2.84) | 0.71 ± 0.44 (0.11–2.84) | 0.52 ± 0.24 (0.17–1.34) |
| p | <0.0001 | <0.0001 | <0.0001 |
| p H–B | <0.0001 | <0.0001 | <0.0001 |
| PNI 0 | 41.68 ± 3.68 (32.00–50.00) | 41.59 ± 3.65 (33.01–49.01) | 41.78 ± 3.74 (32.00–50.00) |
| PNI 1 | 36.95 ± 3.92 (30.00–49.00) | 37.05 ± 4.11 (30.00–47.00) | 36.85 ± 3.75 (30.00–49.00) |
| p | <0.0001 | <0.0001 | <0.0001 |
| p H–B | <0.0001 | <0.0001 | <0.0001 |
p, p-value (Wilcoxon test). Values are presented as means and standard deviations. BMI, body mass index; NRS 2002, Nutritional Risk Score 2002; CRP, C-reactive protein; TLC, total lymphocyte count; PNI, prognostic nutritional index; 0, before treatment; 1, after treatment. H–B, Holm–Bonferroni correction.